These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines. Beidas S; Khamesian M Infect Control Hosp Epidemiol; 1996 Dec; 17(12):773-4. PubMed ID: 8985761 [No Abstract] [Full Text] [Related]
26. Methodology of prevention of antibiotic resistance. Shetty A J Assoc Physicians India; 2010 Dec; 58 Suppl():47-8. PubMed ID: 21568010 [No Abstract] [Full Text] [Related]
30. An audit of teicoplanin use in a district general hospital. Seetulsingh P; Collier S J Hosp Infect; 2006 Oct; 64(2):194-6. PubMed ID: 16831490 [No Abstract] [Full Text] [Related]
31. [Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document]. Rodríguez-Baño J; Paño-Pardo JR; Alvarez-Rocha L; Asensio Á; Calbo E; Cercenado E; Cisneros JM; Cobo J; Delgado O; Garnacho-Montero J; Grau S; Horcajada JP; Hornero A; Murillas-Angoiti J; Oliver A; Padilla B; Pasquau J; Pujol M; Ruiz-Garbajosa P; San Juan R; Sierra R; ; ; Farm Hosp; 2012; 36(1):33.e1-30. PubMed ID: 22137161 [TBL] [Abstract][Full Text] [Related]
32. Implementation problems of decision support system for nosocomial infection. Rems M; Bohanec M; Urh B; Kramar Z Stud Health Technol Inform; 1997; 43 Pt A():358-62. PubMed ID: 10179572 [TBL] [Abstract][Full Text] [Related]
34. Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance. Arda B; Sipahi OR; Yamazhan T; Tasbakan M; Pullukcu H; Tunger A; Buke C; Ulusoy S J Infect; 2007 Jul; 55(1):41-8. PubMed ID: 17512598 [TBL] [Abstract][Full Text] [Related]
35. Development of antibiotic resistance and its audit in our country: how to develop an antibiotic policy. Wattal C Indian J Med Microbiol; 2012; 30(4):381-3. PubMed ID: 23183459 [No Abstract] [Full Text] [Related]
36. Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria. Takesue Y; Nakajima K; Ichiki K; Ishihara M; Wada Y; Takahashi Y; Tsuchida T; Ikeuchi H J Hosp Infect; 2010 May; 75(1):28-32. PubMed ID: 20346536 [TBL] [Abstract][Full Text] [Related]
37. Vaginal & rectal carriage of Streptococcus agalactiae in the Czech Republic: incidence, serotypes distribution & susceptibility to antibiotics. Motlová J; Straková L; Urbásková P; Sak P; Sever T Indian J Med Res; 2004 May; 119 Suppl():84-7. PubMed ID: 15232169 [TBL] [Abstract][Full Text] [Related]
38. [Clinical results and costs due to improved antibiotics policies]. Gyssens IC; Kullberg BJ; van der Meer JW Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2361-4. PubMed ID: 10590774 [TBL] [Abstract][Full Text] [Related]